Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Stent Suit Seeks Injunctive Relief From J&J Market Entry

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific's stent patent suit against Johnson & Johnson's Cordis unit follows by ten days an agreement between J&J and Guidant to co-develop balloon dilatation catheters on a rapid-exchange platform.

You may also be interested in...



Boston Scientific v. J&J

U.S. District Court in Delaware awards Boston Scientific and its stent supplier Medinol $8.3 mil. in damages after finding Johnson & Johnson's Corinthian stent infringes a valid Medinol patent claim, Boston Scientific announced Sept. 7. The jury also found that J&J's Bx Velocity, Crown and Mini Crown stents do not infringe patents owned by Medinol; the complaint was filed in April 2000 (1"The Gray Sheet" May 1, 2000, p. 15). Boston Scientific plans to appeal the mixed verdict if the judge will not agree to set aside the jury's decision

Boston Scientific v. J&J

U.S. District Court in Delaware awards Boston Scientific and its stent supplier Medinol $8.3 mil. in damages after finding Johnson & Johnson's Corinthian stent infringes a valid Medinol patent claim, Boston Scientific announced Sept. 7. The jury also found that J&J's Bx Velocity, Crown and Mini Crown stents do not infringe patents owned by Medinol; the complaint was filed in April 2000 (1"The Gray Sheet" May 1, 2000, p. 15). Boston Scientific plans to appeal the mixed verdict if the judge will not agree to set aside the jury's decision

J&J To Appeal German Stent Patent Suit Ruling In Favor Of Boston Scientific

Johnson & Johnson is in the process of filing an appeal of a May 15 German court ruling that its BX Velocity coronary stent infringes patented Boston Scientific NIR stent technology, the firm says. Boston Scientific is seeking an injunction and damages based on sales.

Related Content

UsernamePublicRestriction

Register

MT013295

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel